Century Therapeutics Funding: $160M Raised, Series C (2021)
Century Therapeutics is based in Philadelphia. It has raised $160M in total funding. Latest round: Series C.
Century Therapeutics funding overview
Century Therapeutics is based in Philadelphia. Century Therapeutics has raised $160M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in March 2021. The round record for Century Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Casdin Capital, Fidelity Management & Research LLC, Federated Hermes Kaufmann Funds, RA Capital, Logos Capital, OrbiMed and 6 others. 12 distinct backers are named across the disclosed rounds.
Frequently asked about Century Therapeutics funding
How much has Century Therapeutics raised?
Century Therapeutics has raised $160M in total disclosed funding across the rounds on record.
Who has invested in Century Therapeutics?
Casdin Capital, Fidelity Management & Research LLC, Federated Hermes Kaufmann Funds, RA Capital, Logos Capital, OrbiMed are named among the investors backing Century Therapeutics.
What was the latest Century Therapeutics funding round?
The most recent disclosed round is a Series C, announced in March 2021.
Where is Century Therapeutics based?
Century Therapeutics is based in Philadelphia.
When did Century Therapeutics last raise?
The last disclosed Century Therapeutics round closed in March 2021 at Series C.
Century Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Philadelphia below to benchmark round size and investor mix.
